Neutralization of cytomegalovirus virions: the role of complement
- PMID: 9237698
- DOI: 10.1086/514050
Neutralization of cytomegalovirus virions: the role of complement
Abstract
Complement provides a key immunologic defense against invading pathogens; thus, a clear understanding of the interactions between cytomegalovirus (CMV) and complement may permit the development of strategies to enhance CMV neutralization. In the presence of specific anti-CMV antibodies, complement enhanced the neutralizing ability of serum by 2- to 3-fold. However, in the absence of specific anti-CMV antibodies, complement was ineffective in neutralizing CMV virions by plaque assay. Although complement alone did not mediate any neutralizing effect, CMV consumed complement activity from seronegative serum, resulting in the deposition of C3 on the virion. However, only in the presence of specific anti-CMV antibody did complement activation continue to the deposition of C9 on the virions. These results strongly suggest complement regulation by CMV virions that is modulated by anti-CMV antibody; this regulation may be attributed to three host complement regulators on the virions: CD55, CD46, and CD59.
Similar articles
-
Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.Viruses. 2018 Apr 25;10(5):219. doi: 10.3390/v10050219. Viruses. 2018. PMID: 29693588 Free PMC article.
-
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).J Immunol. 1995 Nov 1;155(9):4376-81. J Immunol. 1995. PMID: 7594597
-
Humoral immune response to virions and dense bodies of human cytomegalovirus determined by enzyme immunofluorescence assay.J Med Virol. 1980;6(2):119-27. doi: 10.1002/jmv.1890060204. J Med Virol. 1980. PMID: 6264020
-
Complement activation and regulation in rheumatic disease.Semin Immunol. 2019 Oct;45:101339. doi: 10.1016/j.smim.2019.101339. Epub 2019 Nov 9. Semin Immunol. 2019. PMID: 31718864 Review.
-
Viral complement regulatory proteins.Immunopharmacology. 1999 May;42(1-3):99-106. doi: 10.1016/s0162-3109(99)00012-0. Immunopharmacology. 1999. PMID: 10408371 Review.
Cited by
-
Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.J Virol. 2003 Jan;77(1):592-9. doi: 10.1128/jvi.77.1.592-599.2003. J Virol. 2003. PMID: 12477863 Free PMC article.
-
Feeling manipulated: cytomegalovirus immune manipulation.Virol J. 2009 Jan 9;6:4. doi: 10.1186/1743-422X-6-4. Virol J. 2009. PMID: 19134204 Free PMC article.
-
Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.J Virol. 2006 Apr;80(8):4068-78. doi: 10.1128/JVI.80.8.4068-4078.2006. J Virol. 2006. PMID: 16571823 Free PMC article.
-
Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.Immunology. 2008 Feb;123(2):228-38. doi: 10.1111/j.1365-2567.2007.02692.x. Epub 2007 Aug 30. Immunology. 2008. PMID: 17764451 Free PMC article.
-
A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.J Immunol. 2010 Jan 1;184(1):359-68. doi: 10.4049/jimmunol.0902278. Epub 2009 Dec 2. J Immunol. 2010. PMID: 19955519 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
